Associations between the levels of circulating inflammatory adipokines and the risk of type 2 diabetes in Chinese male individuals: A case–control study

Xia Sun,Wei‐Wen Qiu,Jing Wu,Shi‐Ling Ding,Rong‐Zhen Wu
DOI: https://doi.org/10.1002/jcla.24875
IF: 3.124
2023-04-03
Journal of Clinical Laboratory Analysis
Abstract:The levels of circulating inflammatory adipokines associated with the risk of T2D were first explored. Elevated visfatin levels were associated with an increased risk of T2D. The causality relationship between circulating inflammatory adipokines and T2D was not obtained owing to cross‐sectional design. Background treatments for T2D were not available, which may have affected the levels of circulating inflammatory adipokines Background Whether the levels of circulating inflammatory adipokines affect the progression of type 2 diabetes (T2D) remains unclear. This study aimed to assess the association between circulating inflammatory adipokine levels and risk of T2D. Methods This case–control study involved 130 individuals consisting of 66 healthy controls (Control group) and 64 patients with T2D (T2D group) in Lishui Municipal Central Hospital from January 2017 to June 2017. Multivariate logistic regression analysis was applied to assess the associations between circulating inflammatory adipokine levels and the risk of T2D. Results There were significant differences in the levels of adiponectin (p = 0.013) and visfatin (p
medical laboratory technology
What problem does this paper attempt to address?